相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries
Marc Mendelson et al.
LANCET (2016)
Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance
Marguerite L. Monogue et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Price difference as a predictor of the selection between brand name and generic statins in Japan
Osamu Takizawa et al.
HEALTH POLICY (2015)
Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis
Amber O. Molnar et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis
Amber O. Molnar et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review
H. Gothe et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2015)
Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation
Daniele Piovani et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
A Non-inferiority Pilot Study Comparing the Clinical Efficacy and Safety of Generic Wide-spectrum Antibiotic Use in Septic Oncology Patients
I. Araya et al.
DRUG RESEARCH (2015)
Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes A Cohort Study
Joshua J. Gagne et al.
ANNALS OF INTERNAL MEDICINE (2014)
Efficacy and Quality of Antibacterial Generic Products Approved for Human Use: A Systematic Review
Pierre Tattevin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Comparative Effectiveness of Different Oral Antibiotics Regimens for Treatment of Urinary Tract Infection in Outpatients: An Analysis of National Representative Claims Database
Meng-Tse Gabriel Lee et al.
MEDICINE (2014)
International Guidelines for Bioequivalence of Systemically Available Orally Administered Generic Drug Products: A Survey of Similarities and Differences
Barbara Davit et al.
AAPS JOURNAL (2013)
Renal Toxicity Caused by Brand-name Versus Generic Cisplatin: A Comparative Analysis
Seiji Niho et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database
Wen-Shyong Liou et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
A review of covariate selection for non-experimental comparative effectiveness research
Brian C. Sauer et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Bioequivalence Requirements in the European Union: Critical Discussion
Alfredo Garcia-Arieta et al.
AAPS JOURNAL (2012)
Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model
Carlos A. Rodriguez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Generic antibiotics in Japan
Shigeru Fujimura et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Evaluation of Clinical and Safety Outcomes Associated with Conversion from Brand-Name to Generic Tacrolimus in Transplant Recipients Enrolled in an Integrated Health Care System
Michele M. Spence et al.
PHARMACOTHERAPY (2012)
Determinants of generic drug substitution in Switzerland
Anne Decollogny et al.
BMC HEALTH SERVICES RESEARCH (2011)
The Use Of Generic Drugs In Prevention Of Chronic Disease Is Far More Cost-Effective Than Thought, And May Save Money
William H. Shrank et al.
HEALTH AFFAIRS (2011)
Taiwan's National Health Insurance Research Database: administrative health care database as study object in bibliometrics
Yu-Chun Chen et al.
SCIENTOMETRICS (2011)
Generic substitution: micro evidence from register data in Norway
Dag Morten Dalen et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2011)
National Trends in Emergency Department Antibiotic Prescribing for Elders with Urinary Tract Infection, 1996-2005
Jeffrey M. Caterino et al.
ACADEMIC EMERGENCY MEDICINE (2009)
Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Barbara M. Davit et al.
ANNALS OF PHARMACOTHERAPY (2009)
Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?
David Granlund
SOCIAL SCIENCE & MEDICINE (2009)
Generic substitution in the treatment of epilepsy - Case evidence of breakthrough seizures
M. J. Berg et al.
NEUROLOGY (2008)
分享论文
